A German cohort study on autoimmune encephalitis reported a trend toward better mRS outcomes among patients with anti-CASPR2 autoimmune encephalitis who received treatment within 30 days of symptom onset, but this finding did not reach statistical significance ( 14 ).
← all excerpts
Contrasting Outcomes in Two Cases of Anti-contactin-associated Protein-like 2 Autoimmune Encephalitis.
1
—
—